SBI Securities Co. Ltd. Acquires Shares of 1,374 Axon Enterprise, Inc. (NASDAQ:AXON)

SBI Securities Co. Ltd. bought a new position in Axon Enterprise, Inc. (NASDAQ:AXON) in the 4th quarter, Holdings Channel reports. The firm bought 1,374 shares of the biotechnology company’s stock, valued at approximately $817,000.

Other large investors have also recently made changes to their positions in the company. Prestige Wealth Management Group LLC raised its position in Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after purchasing an additional 44 shares during the period. New Wave Wealth Advisors LLC purchased a new stake in shares of Axon Enterprise in the fourth quarter worth approximately $40,000. Brooklyn Investment Group bought a new stake in shares of Axon Enterprise during the 3rd quarter worth approximately $41,000. Y.D. More Investments Ltd purchased a new position in Axon Enterprise during the 4th quarter valued at $45,000. Finally, Planning Capital Management Corp grew its position in Axon Enterprise by 83.3% in the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock valued at $48,000 after acquiring an additional 55 shares during the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Axon Enterprise Price Performance

Shares of AXON stock opened at $525.75 on Tuesday. The stock’s 50-day moving average is $607.58 and its 200 day moving average is $526.43. Axon Enterprise, Inc. has a 1-year low of $273.52 and a 1-year high of $715.99. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The company has a market cap of $40.09 billion, a P/E ratio of 135.85, a PEG ratio of 5.17 and a beta of 1.05.

Insider Buying and Selling at Axon Enterprise

In other news, Director Julie A. Cullivan sold 1,261 shares of the company’s stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total transaction of $860,077.66. Following the transaction, the director now directly owns 2,392 shares of the company’s stock, valued at approximately $1,631,487.52. This represents a 34.52 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Michael Garnreiter sold 1,000 shares of the stock in a transaction on Monday, December 16th. The shares were sold at an average price of $639.69, for a total value of $639,690.00. Following the sale, the director now owns 24,259 shares of the company’s stock, valued at approximately $15,518,239.71. This represents a 3.96 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 6,407 shares of company stock valued at $4,122,925. 6.10% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the company. Northcoast Research downgraded Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. JMP Securities reiterated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Northland Securities upped their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research note on Monday, November 11th. The Goldman Sachs Group lifted their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research note on Monday, January 27th. Finally, Craig Hallum cut Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 price objective on the stock. in a research note on Thursday, February 20th. Three equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $587.38.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.